Related Experiment Video
Updated: Dec 7, 2025
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.2K
Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice
J Kevin Hicks1, Christina L Aquilante1, Henry M Dunnenberger1
1American College of Clinical Pharmacy.
Journal of the American College of Clinical Pharmacy : JACCP
|September 28, 2020
Summary
Clinical pharmacogenomics advances precision pharmacotherapy by guiding drug selection and dosing. This paper details real-world applications and recommends how the American College of Clinical Pharmacy can advance its implementation, education, and research.
Area of Science:
- Pharmacology
- Genetics
- Clinical Pharmacy
Background:
- Precision pharmacotherapy integrates patient-specific factors for optimized drug therapy.
- Clinical pharmacogenomics, a rapidly evolving field, is central to personalized medicine.
- Clinical pharmacists are crucial in implementing and advancing pharmacogenomics.
Purpose of the Study:
- To articulate real-world clinical applications of precision pharmacotherapy via clinical pharmacogenomics.
- To provide recommendations for the American College of Clinical Pharmacy (ACCP) to support pharmacogenomics advancement.
- To identify commonalities in successful pharmacogenomics programs for broader implementation.
Main Methods:
- Review of clinical applications of precision pharmacotherapy, focusing on pharmacogenomics.
- Analysis of successful clinical pharmacogenomics implementation and education programs.
- Development of recommendations for ACCP to foster pharmacogenomics practice, education, and research.
Main Results:
- Clinical pharmacogenomics offers practical applications in guiding drug selection and dosing.
- Key commonalities exist in successful pharmacogenomics implementation and education initiatives.
- ACCP can play a vital role in advancing clinical pharmacogenomics through targeted support.
Conclusions:
- Clinical pharmacogenomics is integral to precision pharmacotherapy, with pharmacists leading its integration.
- Strategic support from ACCP is essential for expanding pharmacogenomics education, implementation, and research.
- Further research is needed to fully realize the potential of pharmacogenomics in clinical practice.
Keywords:
clinical pharmacypersonalized medicinepharmacogenomicspharmacy practiceprecision pharmacotherapyMore Related Videos
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.0K
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
75
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
75
01:24Dosage Regimen: Individualization
96
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
96
01:12Analysis of Population Pharmacokinetic Data
585
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
585
01:19Nonlinear Pharmacokinetics: Overview
875
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
875
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
01:16Therapeutic Drug Monitoring: Overview and Classification
151
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
151